Page Tools:

Cancer Therapy: Prescribing and Administration Basics

Author(s): Trinh Pham, PharmD, BCOP, Associate Professor, University of Connecticut School of Pharmacy, Storrs, Connecticut
Lisa Holle, PharmD, BCOP, Assistant Clinical Professor, University of Connecticut School of Pharmacy, Storrs, Connecticut
Details:
  • ISBN-13: 9781449633974
  • Paperback    362 pages      © 2015
Price: $93.95 US List
Add to Cart Request a Review Copy

Cancer Therapy: Prescribing and Administration Basics is a helpful handbook that guides multidisciplinary hematology/oncology practitioners in the practical, day-to-day aspects of cancer therapy prescribing, verification, admixing, administration, and billing. This valuable resource will help practitioners to optimize patient compliance, drug efficacy, and safety by providing patient counseling tips, proper safety and dispensing of oral cancer therapy information, and clinically significant drug interactions.

Cancer Therapy: Prescribing and Administration Basics is also a useful text for healthcare professionals whose primary area of practice is not hematology/oncology but who may be responsible for verifying, preparing, dispensing, or administering cancer therapy agents. This valuable text will provide them with practical information to accurately verify cancer therapy orders before drug preparation and administration and ensure safe use.

Features & Benefits

• Dosing calculations in obese and pediatric patient populations

• The difference between writing, verifying, and administering normal/dose versus high/dose cancer therapy

• A checklist of factors to consider for appropriate cancer therapy prescribing, verifying, and admixing before administration

• Practical issues to consider for different routes or methods of cancer therapy administration (eg, intrathecal, intraperitoneal, outpatient continuous infusion pumps, oral)

• Real-life case examples, practice cases, and clinical pearls and tips

Chapter  1  Overview of Cancer Therapy
Chapter  2  Basics of Systemic Anticancer Therapy Prescribing and Verification
Chapter  3  Dosing Calculations
Chapter  4  Cancer Therapy Preparation
Chapter  5  Oral Cancer Therapy
Chapter  6  Drug Safety and Risk Management
Chapter  7  Inventory and Reimbursement
Chapter  8  High-Dose Cancer Therapy
Chapter  9  Pediatric Oncology
Chapter  10  Investigational Drugs
Chapter  11  Pharmacogenomics

Trinh Pham, PharmD, BCOP-Associate Professor, University of Connecticut School of Pharmacy, Storrs, Connecticut

Trinh Pham, PharmD, BCOP is an Associate Clinical Professor at the University of Connecticut’s School of Pharmacy. Her practice site is at the Yale New Haven Hospital, Smilow Cancer Center where she provides education to the oncology pharmacists, pharmacy residents, and pharmacy students along with the medical oncology team in the areas of pain management and supportive care. Dr. Pham completed her Bachelor of Science in Pharmacy at the University of Texas in Austin. She also completed a post-baccalaureate Doctor of Pharmacy and a specialized oncology residency and fellowship at the University of Oklahoma. Dr. Pham is a board certified oncology pharmacist. Her clinical and research interests include pain management and supportive care. Dr. Pham is a member of the Hematology/Oncology Pharmacy Association and the American Society of Clinical Oncology.

 

Lisa Holle, PharmD, BCOP-Assistant Clinical Professor, University of Connecticut School of Pharmacy, Storrs, Connecticut

Lisa M. Holle, PharmD, BCOP is an Assistant Clinical Professor at the University of Connecticut’s School of Pharmacy. Her practice site is at the University of Connecticut Health Center’s Carole and Ray Neag Comprehensive Cancer Center, where she works with the medical oncology team to provide management of oral cancer therapy, supportive care, and pain management. Dr. Holle completed her Bachelor of Science in Pharmacy and a post-baccalaureate Doctor of Pharmacy from the University of Wisconsin at Madison. She completed a specialized oncology residency at UT M.D. Anderson Cancer Center, and is a board certified oncology pharmacist. Dr. Holle is a Past President of the Hematology/Oncology Pharmacy Association (HOPA) and is a member of many professional pharmacy and oncology organizations. Her clinical research program focuses on oncology quality improvement initiatives, drug shortages, oral cancer therapy management, and reimbursement for clinical pharmacy services. Other clinical and research interests include reimbursement, supportive care, survivorship, and pharmacy teaching methods.